Medpace Holdings (MEDP) Reveals "Shocking" Bookings Miss, Shares Fall - Hagens Berman
Here's Why Medpace (MEDP) Detracted in Q3
Looking Into Medpace Hldgs's Recent Short Interest
We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
Assessing Medpace Hldgs: Insights From 9 Financial Analysts
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
Express News | Medpace Holdings Inc : UBS Cuts to Neutral From Buy
UBS Downgrades Medpace(MEDP.US) to Hold Rating, Cuts Target Price to $350
Maintaining Hold on Medpace Holdings Amid Market Headwinds and Revised Growth Expectations
Medpace (MEDP) Outperforms Broader Market: What You Need to Know
Medpace Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Cut Its Price Target From $415 to $345.
Medpace, Fortrea Cut as Jefferies Reviews CROs Amid Biotech Headwinds
Jefferies Downgrades Medpace Holdings to Hold From Buy, Price Target Is $345
Medpace Holdings, Inc. (MEDP): A Bull Case Theory
Medpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024
Medpace Holdings Is Maintained at Outperform by Baird
Baird Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $413
Baird analyst Eric Coldwell maintains $Medpace(MEDP.US)$ with a buy rating, and adjusts the target price from $430 to $413.According to TipRanks data, the analyst has a success rate of 54.2% and a
Express News | Medpace Holdings Inc : Baird Cuts Target Price to $413 From $430
Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs